We launched a clinical trial (press release) to test whether curcumin – an extract from the curry spice turmeric – could improve treatment for advanced bowel cancer. This doesn’t mean curry cures cancer (as we pointed out here), or that people with bowel
Read Full Article atCALGARY, March 28, 2013 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC) (NASDAQ:ONCY) today announced that it has met the primary overall statistical endpoint in its U.S. Phase 2 single arm clinical trial in patients with
Among African-American men, baldness is associated with a higher risk of prostate cancer, finds study published in Cancer Epidemiology, Biomarkers & Prevention. "We focused on African-American men because they are at high risk for developing prostate can
The biggest-ever trawl of the human genome for cancer-causing DNA errors has netted more than 80 tiny mutations, a finding that could help people at high risk, researchers said Wednesday. The results, which double the number of known genetic alterations
More and more people are surviving cancer, thanks to earlier detection and better treatment, and a new report out Wednesday projects the ranks of cancer survivors will grow by nearly a third over the next 10 years. That’s the good news. The bad news: the
LONDON, March 28 (Reuters) - Pfizer suffered a second rejection in two days from Britain's health cost watchdog NICE as its new kidney cancer drug Inlyta was turned down for use on the state health service. The National Institute for Health and Clinical
NEW YORK -- A huge international effort involving more than 100 institutions and genetic tests on 200,000 people has uncovered dozens of signposts in DNA that can help reveal further a person's risk for breast, ovarian or prostate cancer, scientists repo
